Importantly, expression of ZBTB16 itself was predictive of survival in patients with luminal A cancer, with high expression relating to favorable PFS and low expression to poor PFS, the latter with comparable outcomes as observed for luminal B subtype (Fig 3I). This evidence concerns the gene ZBTB16 and cancer.